Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib.
Blood Cancer J
; 5: e338, 2015 Aug 14.
Article
in En
| MEDLINE
| ID: mdl-26275080
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Boron Compounds
/
Glycine
/
Multiple Myeloma
/
Antineoplastic Agents
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood Cancer J
Year:
2015
Document type:
Article
Affiliation country:
United States
Country of publication:
United States